MYCN and retinoblastoma: A recent study classified two RB subtypes [4] displaying different molecular and histological features, with RB subtype 2 tumors showing higher metastatic potential, expressing the recently identified marker trefoil factor family peptid 1 (TFF1) [4–8] and harboring MYCN gene amplifications [4].